Is PSG.DE stock a buy for a short-term bounce?

PSG.DE stock shows a short-term bounce setup pre-market at **€29.00**, with rel vol **2.30** and support at **€28.52**. Traders can consider a tactical long with a tight stop, but manage risk and monitor volume and company news.

What are realistic price targets for PSG.DE stock?

For a tactical oversold bounce we set a near target at **€31.00** and a secondary at **€33.00**. Meyka AI's 3‑year model target is **€29.48** and 5‑year **€31.56**. These figures are model projections and not guarantees.

How does PSG.DE stock compare to the healthcare sector?

PSG.DE stock trades at **PE 17.26**, below the sector average near **31.63**, and shows strong margins and low debt. That relative valuation can attract buyers when short-term technicals trigger a bounce.

Where can I find official PSG.DE filings and company news?

Check PharmaSGP’s investor pages at [PharmaSGP website](https://pharmasgp.com) and the official exchange profile at [Börse Frankfurt](https://www.boerse-frankfurt.de/equities/pharmasgp-holding-se) for filings and announcements.

DE Stocks

Pre-market: PSG.DE (PharmaSGP SE XETRA) €29.00 oversold bounce: key level €28.52

ByDanny Kontos January 15, 2026January 15, 2026

The PSG.DE stock opened pre-market at €29.00 on XETRA on 15 Jan 2026 and shows an early oversold bounce setup versus short-term averages. We see volume running at 12,424 shares, or 2.30x average, a sign of heightened interest. Price sits just above the 50‑day at €28.52 and below the year high of €30.00, which frames an actionable short-term trade for traders watching an oversold bounce strategy. Below we break down market signals, valuation, risk, and price targets for PharmaSGP Holding SE on XETRA in Germany.